Thousands of COVID tests recalled over bacteria risk, FDA warns

Canada News News

Thousands of COVID tests recalled over bacteria risk, FDA warns
Canada Latest News,Canada Headlines
  • 📰 CBSNews
  • ⏱ Reading Time:
  • 14 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 68%

Thousands of COVID tests should be thrown out immediately over bacteria risk, the FDA warns.

tests from Roche and SD Biosensor should be thrown out immediately, the Food and Drug Administration is warning, citing"significant concerns" over bacteria that could infect users of the tests.. 500,000 were distributed to CVS and 16,000 to Amazon.testing programs"SD Biosensor Inc., the manufacturer of the Pilot COVID-19 At-Home Test, informed Roche that this issue was identified during routine quality assurance testing.

So far, the FDA says it has not received any reports of injuries or deaths linked to contaminated tests. Evie Baik, a spokesperson for SD Biosensor, said in a statement that their probe has identified raw materials from one of their suppliers as the likely culprit.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CBSNews /  🏆 87. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Smelling salt products promise an 'energy boost,' but have reportedly caused seizures, FDA warnsSmelling salt products promise an 'energy boost,' but have reportedly caused seizures, FDA warnsThe Food and Drug Administration warned that unapproved inhalant products containing ammonia may pose health risks.
Read more »

FDA approves world's first RSV vaccine, a shot for adults ages 60 and upFDA approves world's first RSV vaccine, a shot for adults ages 60 and upBREAKING: FDA approves the world's first respiratory syncytial virus, or RSV, vaccine made by pharmaceutical giant GSK.
Read more »

FDA approves first vaccine for RSV, a moment six decades in the making | CNNFDA approves first vaccine for RSV, a moment six decades in the making | CNNAfter a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV -- and more are on the way.
Read more »

FDA approves GSK RSV vaccineFDA approves GSK RSV vaccineGSK's Arexvy, the first RSV vaccine approved for use in the U.S., gets the green light for older adults.
Read more »

FDA approves first RSV vaccine to protect older adultsFDA approves first RSV vaccine to protect older adultsUp to 10,000 deaths and 160,000 hospitalizations a year are caused by RSV.
Read more »



Render Time: 2025-02-28 14:30:53